Specialization of tumour vasculature

被引：558

作者：

Ruoslahti, E ^{[1
]}

机构：

[1] Burnham Inst, Ctr Canc Res, La Jolla, CA 92037 USA

来源：

NATURE REVIEWS CANCER | 2002年 / 2卷 / 02期

关键词：

D O I：

10.1038/nrc724

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Tumour blood vessels express markers that are not present in resting blood vessels of normal tissues, but that can be shared by angiogenic vessels in non-malignant conditions. Many of these proteins are functionally important in the angiogenic process. Some tumours also contain lymphatic vessels, as well as channels that consist of cancer cells and their extracellular matrix. These special features of tumour vessels are good targets for cancer therapies.

引用

页码：83 / 90

页数：8

共 82 条

[1] Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
Arap, W
Pasqualini, R
Ruoslahti, E
[J]. SCIENCE, 1998, 279 (5349) : 377 - 380
[2] Solution structures and integrin binding activities of an RGD peptide with two isomers
Assa-Munt, N
Jia, X
Laakkonen, P
Ruoslahti, E
[J]. BIOCHEMISTRY, 2001, 40 (08) : 2373 - 2378
[3] Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all αv integrins
Bader, BL
Rayburn, H
Crowley, D
Hynes, RO
[J]. CELL, 1998, 95 (04) : 507 - 519
[4] Lack of specificity of endoglin expression for tumor blood vessels
Balza, E
Castellani, P
Zulstra, A
Neri, D
Zardi, L
Siri, A
[J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (04) : 579 - 585
[5] CD13/APN is activated by angiogenic signals and is essential for capillary tube formation
Bhagwat, SV
Lahdenranta, J
Giordano, R
Arap, W
Pasqualini, R
Shapiro, LH
[J]. BLOOD, 2001, 97 (03) : 652 - 659
[6] Platelet-derived growth factor receptor β and vascular endothelial growth factor receptor 2 bind to the β3 integrin through its extracellular domain
Borges, E
Jan, YW
Ruoslahti, E
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (51) : 39867 - 39873
[7] Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries -: Podoplanin as a specific marker for lymphatic endothelium
Breiteneder-Geleff, S
Soleiman, A
Kowalski, H
Horvat, R
Amann, G
Kriehuber, E
Diem, K
Weninger, W
Tschachler, E
Alitalo, K
Kerjaschki, D
[J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (02) : 385 - 394
[8] REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS
BROOKS, PC
CLARK, RAF
CHERESH, DA
[J]. SCIENCE, 1994, 264 (5158) : 569 - 571
[9] ANTIINTEGRIN ALPHA-V-BETA-3 BLOCKS HUMAN BREAST-CANCER GROWTH AND ANGIOGENESIS IN HUMAN SKIN
BROOKS, PC
STROMBLAD, S
KLEMKE, R
VISSCHER, D
SARKAR, FH
CHERESH, DA
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) : 1815 - 1822
[10] A novel approach for the identification of unique tumor vasculature binding peptides using an E-coli peptide display library
Brown, CK
Modzelewski, RA
Johnson, CS
Wong, MKK
[J]. ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (10) : 743 - 749

← 1 2 3 4 5 6 7 8 9 →